Nanosphere names new director
Mr Randall brings to Nanosphere’s board of directors extensive senior executive and independent board member experience in the healthcare, manufacturing and technology industries. Mr Randall has previous experience
The US Food and Drug Administration (FDA) has approved an expanded indication for Eli Lilly and Company’s Jaypirca (pirtobrutinib) as a first-line treatment for adults with previously untreated chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL) who do not have a 17p deletion.
Previously, GlaxoSmithKline’s (GSK) subsidiary in Greece, GSK AEVE, stopped supplying Greek wholesalers in November 2000, citing product shortages, and started distributing to hospitals and pharmacies directly. Consequently, wholesalers